“We risk no longer being able to immunize infants in hospital”

The Beyfortus drug which immunizes infants (and young children) is poorly reimbursed and may no longer be available in hospitals, the pediatric community is concerned. She has a radically different opinion from that of the High Health Authority on the benefits of the product.

close

Why is Beyfortus (nirsevimab) only 30% reimbursed, the entire pediatric community is outraged in a press release? “It’s the medication for bronchiolitis that we’ve been waiting for decades for,” assure Professor Christèle Gras-Le Guen. The Nantes pediatrician orchestrated the first immunization campaign for newborns last year. 250,000 doses acquired by the State from Sanofi had been injected.

In the opinion of doctors, the monoclonal antibody has kept its promises. Two studies published in…